MAPT and Alzheimer disease: Conversely, the PLB1-triple mouse model of AD, expressing, APP, Tau and PSEN1 transgenes, shows a profile of oscillatory changes that includes an increase in delta power, and resembles EEG slowing present in AD patients [41].